Iridex Corp
$0.61
-$0.03 (-4.03%)
$0.61Day Range$0.67
Key Statistics
Market Cap
$10.66M
Shares Outstanding
17.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 16, 1996
Round Lot
100
Locale
US
Trading Data
Day Open
$0.63
Day High
$0.67
Day Low
$0.61
Volume
64.9K
VWAP
$0.62
Prev Close
$0.63
Transactions
--
Acc. Volume
--
About Iridex Corp
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSSIC 3845108 employees1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA, 94043(650) 940-4700IPO Feb 16, 1996US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001006045
- Composite FIGI
- BBG000BZB346
- Share Class FIGI
- BBG001S7J0Y3
- Ticker Root
- IRIX
- SIC Code
- 3845
About Iridex Corp (IRIX) Stock
Iridex Corp (IRIX) closed the 2026-09-16 session at $0.61, down 4.03% versus the previous close (-0.03). The stock opened at $0.63 and traded between $0.61 and $0.67 during that session. Session trading volume was 65K shares. The volume-weighted average price (VWAP) is $0.62.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Iridex Corp has a market capitalization of $10.7 million. The company operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry classification. IRIX is listed on the XNAS exchange. The company employs approximately 108 people. Iridex Corp is headquartered in MOUNTAIN VIEW, CA. The recorded listing date is 1996-02-16.
On this page you can find market IRIX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector.